Literature DB >> 951732

Delayed overt hemolytic transfusion reaction due to anti-U antibody.

I K Rothman, H J Alter, G J Strewler.   

Abstract

A patient is described who developed a delayed hemolytic transfusion reaction, 11 days posttransfusion, caused by anti-U. This case illustrates the difficulty that can occur in distinguishing a delayed transfusion reaction from autoimmune hemolytic disease when the antibody involved is directed against a high incidence blood group antigen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 951732     DOI: 10.1046/j.1537-2995.1976.16476247058.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  Anti-U alloimmunisation in a pregnant woman from Niger.

Authors:  Alvaro Ringressi; Sara Biagioni; Giorgio Mello; Gabriele Graziani; Federico Mecacci
Journal:  Blood Transfus       Date:  2012-02-13       Impact factor: 3.443

2.  Generation of 'designer erythroblasts' lacking one or more blood group systems from CRISPR/Cas9 gene-edited human-induced pluripotent stem cells.

Authors:  Priyanka Pandey; Nanyan Zhang; Brian R Curtis; Peter J Newman; Gregory A Denomme
Journal:  J Cell Mol Med       Date:  2021-09-21       Impact factor: 5.310

3.  Importance of Life-Long Alerts in Electronic Medical Report Systems for Patients With Positive Antigen Screening.

Authors:  Bianca C Woodruff; Lazar Popilevsky; Roni Mendonca; Michael Girshin
Journal:  Cureus       Date:  2022-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.